AR
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | 2022 | 175 | 49 | |||
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients? | Current treatment options in oncology | 2022 | 61 | 17 | |||
Prostate cancer nonascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: 3 case reports and review of the literature | Urology | 2020 | 265 | 0 | |||
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma | Scientific Reports | 2019 | 219 | 803 | |||
Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review | Critical reviews in oncology/hematology | 2018 | 235 | 0 | |||
Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma | Digestive and Liver Disease | 2017 | 506 | 1 | |||
Reversibility of Chemotherapy-Related Liver Injury | Journal of hepatology | 2017 | 627 | 0 | |||
Prise en charge multidisciplinaire du cancer localisé du rectum | Revue médicale suisse | 2017 | 673 | 295 | |||
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer | Digestive and Liver Disease | 2017 | 485 | 0 | |||
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer | Clinical cancer research | 2016 | 506 | 4 | |||
Management of patients with colorectal liver metastasis in eleven questions and answers | Expert review of anticancer therapy | 2016 | 679 | 2 | |||
Epidémiologie, prise en charge et suivi des polypes colorectaux | Revue médicale suisse | 2016 | 468 | 1 | |||
Prise en charge de la carcinose péritonéale par chirurgie cytoréductive et chimiothérapie hyperthermique intrapéritonéale | Revue médicale suisse | 2016 | 745 | 339 | |||
Single Nucleotide Polymorphism (rs4932178) in the P1 Promoter of FURIN Is Not Prognostic to Colon Cancer | BioMed research international | 2015 | 486 | 218 | |||
Rectal Outcomes After a Liver-First Treatment of Patients with Stage IV Rectal Cancer | Annals of surgical oncology | 2015 | 826 | 0 | |||
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial | Annals of oncology | 2015 | 537 | 0 | |||
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial | Lancet | 2015 | 580 | 0 | |||
Response to:Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data | Journal of the National Cancer Institute | 2015 | 487 | 0 | |||
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance | Molecular oncology | 2015 | 502 | 0 | |||
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06) | Annals of oncology | 2015 | 545 | 1 | |||
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative | European journal of cancer | 2015 | 549 | 302 | |||
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer | Clinical colorectal cancer | 2015 | 643 | 543 | |||
Cancers superficiels de l'œsophage : épidémiologie, diagnostic et traitement | Revue médicale suisse | 2015 | 428 | 3 | |||
Création du Centre du cancer de la prostate des HUG | Revue médicale suisse | 2014 | 670 | 2 | |||
Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics | Asia-Pacific journal of clinical oncology | 2014 | 562 | 0 | |||
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features | Annals of oncology | 2014 | 591 | 0 | |||
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum | European journal of cancer | 2014 | 521 | 3 | |||
Cancers superficiels de l'estomac : épidémiologie, diagnostic et prise en charge | Revue médicale suisse | 2014 | 542 | 0 | |||
Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer | BMC surgery | 2014 | 806 | 212 | |||
European perspective for effective cancer drug development | Nature Reviews Clinical Oncology 1759-4782] | 2014 | 672 | 0 | |||
Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control | International journal of radiation oncology, biology, physics | 2013 | 608 | 0 | |||
EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe | European journal of cancer | 2013 | 528 | 1 | |||
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer | Journal of pathology | 2013 | 539 | 1,543 | |||
Registry of gastric cancer treatment evaluation (REGATE): II treatment practice | Asia-Pacific journal of clinical oncology | 2013 | 512 | 0 | |||
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis | Journal of the National Cancer Institute | 2013 | 536 | 0 | |||
Common bile duct adenocarcinoma in a patient with situs inversus totalis: report of a rare case | BMC research notes | 2012 | 623 | 261 | |||
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer | Journal of the National Cancer Institute | 2012 | 546 | 584 | |||
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy? | Radiotherapy and oncology | 2012 | 696 | 0 | |||
Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases | World journal of surgery | 2012 | 743 | 0 | |||
A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study | Annals of surgery | 2012 | 760 | 0 | |||
Management of peritoneal carcinomatosis by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy | Swiss knife | 2011 | 714 | 386 | |||
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010 | Annals of oncology | 2011 | 574 | 0 | |||
Prise en charge du carcinome du canal anal | Revue médicale suisse | 2011 | 534 | 0 | |||
Successful closure of anal cancer-related fistulas with upfront intra-arterial chemotherapy: a report of 8 cases | Diseases of the colon & rectum | 2011 | 534 | 0 | |||
Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers | BMC cancer | 2011 | 590 | 416 | |||
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study | Journal of gastroenterology and hepatology | 2011 | 692 | 0 | |||
Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer | Schweizerische medizinische Wochenschrift | 2011 | 751 | 354 | |||
Thérapies ciblées en oncologie digestive | Revue médicale suisse | 2011 | 515 | 0 | |||
Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle | Journal of the National Cancer Institute | 2011 | 580 | 1 | |||
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial | Journal of clinical oncology | 2010 | 552 | 0 | |||
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery | The oncologist | 2010 | 570 | 0 | |||
Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes | Annals of surgical oncology | 2010 | 718 | 244 | |||
Cancer de l'oesophage: traitement multidisciplinaire | Revue médicale suisse | 2010 | 710 | 0 | |||
Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03) | Onkologie | 2010 | 498 | 0 | |||
Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06) | The oncologist | 2010 | 577 | 0 | |||
Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer | World journal of gastroenterology | 2010 | 421 | 0 | |||
Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases | British journal of surgery | 2009 | 664 | 0 | |||
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib | European journal of cancer | 2009 | 508 | 0 | |||
Cancer gastrique, une prise en charge multidisciplinaire | Revue médicale suisse | 2009 | 687 | 0 | |||
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02) | Annals of oncology | 2009 | 576 | 0 | |||
Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial | Clinical cancer research | 2009 | 529 | 0 | |||
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? | Supportive care in cancer | 2009 | 470 | 0 | |||
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3 | Journal of clinical oncology | 2009 | 584 | 0 | |||
'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases | Digestive surgery | 2008 | 787 | 0 | |||
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer | European journal of cancer | 2008 | 629 | 0 | |||
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group | European journal of cancer | 2008 | 587 | 0 | |||
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK | Annals of oncology | 2008 | 586 | 0 | |||
Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score | Annals of surgical oncology | 2008 | 808 | 282 | |||
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research | Journal of clinical oncology | 2007 | 536 | 0 | |||
Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour | European journal of surgical oncology | 2007 | 658 | 0 | |||
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers | Investigational new drugs | 2007 | 503 | 0 | |||
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery | Annals of oncology | 2007 | 776 | 0 | |||
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006 | Annals of oncology | 2007 | 534 | 522 | |||
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma | Annals of oncology | 2007 | 555 | 1,252 | |||
Response from authors: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93: 872-878) | British journal of surgery | 2007 | 489 | 0 | |||
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005 | Annals of oncology | 2006 | 552 | 422 | |||
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary | British journal of surgery | 2006 | 699 | 0 | |||
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study | British journal of cancer | 2006 | 573 | 262 | |||
Author's reply: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (British Journal of Surgery 2006; 93: 872–878) | British journal of surgery | 2006 | 416 | 0 | |||
Complete closure of cancer-related anovaginal and anoperineal fistulas in locally advanced anal canal carcinomas by upfront intra-arterial chemotherapy followed by combined radiochemotherapy: report of two cases | Diseases of the colon & rectum | 2006 | 813 | 0 | |||
Authors' reply: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg) 2006; 93; 872–878 | British journal of surgery | 2006 | 474 | 0 | |||
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study | Annals of oncology | 2005 | 641 | 299 | |||
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial | International journal of radiation oncology, biology, physics | 2005 | 677 | 0 | |||
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study | International journal of radiation oncology, biology, physics | 2005 | 681 | 0 | |||
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity | Annals of oncology | 2005 | 571 | 256 | |||
Nouveaux traitements systémiques dans le cancer du pancréas avancé : implications sur la survie et considérations médicoéconomiques | Revue médicale suisse | 2005 | 468 | 1 | |||
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial | The cancer journal | 2005 | 675 | 0 | |||
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study | British journal of cancer | 2005 | 557 | 178 | |||
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial | Annals of oncology | 2004 | 506 | 157 | |||
Docetaxal et cancer gastrique | Bulletin du cancer | 2004 | 406 | 0 | |||
Chemotherapeutic options in the management of anal cancer | Expert opinion on pharmacotherapy | 2004 | 689 | 0 | |||
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer | Annals of oncology | 2004 | 749 | 832 | |||
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer | British journal of cancer | 2003 | 535 | 200 | |||
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II study | Annals of oncology | 2003 | 689 | 599 | |||
Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial results | European radiology | 2003 | 544 | 1 | |||
Chemotherapy in gastric cancer: a never ending saga | Annals of oncology | 2003 | 493 | 0 | |||
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial | Journal of clinical oncology | 2003 | 536 | 0 | |||
Docetaxel-based chemotherapy in the treatment of gastric cancer | Annals of oncology | 2003 | 639 | 224 | |||
Curative treatment of gastric cancer: towards a multidisciplinary approach? | Critical reviews in oncology/hematology | 2003 | 489 | 0 | |||
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial | Journal of clinical oncology | 2003 | 486 | 0 | |||
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001) | European journal of cancer | 2002 | 486 | 0 | |||
Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trial | International journal of radiation oncology, biology, physics | 2002 | 612 | 0 | |||
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer | Journal of clinical oncology | 2002 | 441 | 0 | |||
European experience of docetaxel and cisplatin in advanced gastric cancer | Gastric cancer | 2002 | 479 | 0 | |||
Prise en charge multidisciplinaire du cancer colorectal héréditaire | Swiss surgery | 2001 | 746 | 0 | |||
Thermoablation percutanée de tumeurs hépatiques par radiofréquence | Médecine et hygiène | 2001 | 646 | 0 | |||
Approche diagnostique et thérapeutique des métastases hépatiques d'origine colorectale | Médecine et hygiène | 2000 | 664 | 0 | |||
Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential | British journal of cancer | 2000 | 784 | 211 | |||
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) | Annals of oncology | 2000 | 412 | 182 | |||
Approche multidisciplinaire du cancer rectal | Médecine et hygiène | 2000 | 598 | 5 | |||
Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy | Annals of the New York Academy of Sciences | 2000 | 528 | 1 | |||
Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study | Anticancer research | 2000 | 529 | 1 | |||
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Lancet | 2000 | 486 | 0 | |||
Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy | Cancer | 1999 | 479 | 0 | |||
High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas | Acta oncologica | 1999 | 455 | 140 | |||
Les tumeurs bénognes et malignes associées à la polypose adénomateuse familiale | Médecine et hygiène | 1999 | 553 | 0 | |||
Wilms' tumor in the adult--report of a case and review of the literature | Pathology, research and practice | 1999 | 516 | 0 | |||
Effets du traitement néoadjuvant sur la chirurgie des tumeurs digestives avec extension locorégionale | Médecine et hygiène | 1998 | 554 | 0 | |||
Colon cancers and peritoneal mesothelioma occurring 29 years after abdominal radiation for testicular seminoma. A case report and review of the literature | Oncology | 1998 | 552 | 0 | |||
Results of surgical resection of liver metastases from non-colorectal primaries | British journal of surgery | 1998 | 750 | 0 | |||
Syndrome de déficit immunitaire acquis, coccidiose chronique, et septicémie à Salmonella typhi murium chez un couple de zairois. Fonctions immunitaires et essai d'immunostimulation par la thymopentine | Schweizerische medizinische Wochenschrift | 1984 | 660 | 0 |